1128 related articles for article (PubMed ID: 21937200)
101. Primary cutaneous follicular helper T-cell lymphoma: a new subtype of cutaneous T-cell lymphoma reported in a series of 5 cases.
Battistella M; Beylot-Barry M; Bachelez H; Rivet J; Vergier B; Bagot M
Arch Dermatol; 2012 Jul; 148(7):832-9. PubMed ID: 22508770
[TBL] [Abstract][Full Text] [Related]
102. Characteristics of cutaneous lymphomas in Osaka, Japan (1988-1999) based on the European Organization for Research and Treatment of Cancer classification.
Nagasawa T; Miwa H; Nakatsuka S; Itami S; Yoshikawa K; Aozasa K
Am J Dermatopathol; 2000 Dec; 22(6):510-4. PubMed ID: 11190442
[TBL] [Abstract][Full Text] [Related]
103. Clinical spectrum of primary cutaneous CD30-positive anaplastic large cell lymphoma: an analysis of the Mannheim Cutaneous Lymphoma Registry.
Booken N; Goerdt S; Klemke CD
J Dtsch Dermatol Ges; 2012 May; 10(5):331-9. PubMed ID: 22525148
[TBL] [Abstract][Full Text] [Related]
104. Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells.
Felcht M; Heck M; Weiss C; Becker JC; Dippel E; Müller CS; Nashan D; Sachse MM; Nicolay JP; Booken N; Goerdt S; Klemke CD
Br J Dermatol; 2012 Aug; 167(2):348-58. PubMed ID: 22512270
[TBL] [Abstract][Full Text] [Related]
105. Clinicopathologic reassessment of non-mycosis fungoides primary cutaneous lymphomas during 17 years.
Bergman R; Marcus-Farber BS; Manov L; Nerodinisky I; Epelbaum R; Sahar D; Schein-Goldschmid R; Ramon M; Ben-Arieh Y
Int J Dermatol; 2002 Nov; 41(11):735-43. PubMed ID: 12452994
[TBL] [Abstract][Full Text] [Related]
106. Local radiation for cutaneous T-cell lymphoma other than mycosis fungoides and Sézary syndrome.
Shikama N
Chin Clin Oncol; 2019 Feb; 8(1):8. PubMed ID: 30180750
[TBL] [Abstract][Full Text] [Related]
107. Prevalence and severity of pruritus in cutaneous T cell lymphoma.
Vij A; Duvic M
Int J Dermatol; 2012 Aug; 51(8):930-4. PubMed ID: 22788808
[TBL] [Abstract][Full Text] [Related]
108. Non-mycosis fungoides cutaneous lymphomas in a referral center in Taiwan: A retrospective case series and literature review.
Liu KL; Tsai WC; Lee CH
PLoS One; 2020; 15(1):e0228046. PubMed ID: 31978091
[TBL] [Abstract][Full Text] [Related]
109. Pentostatin treatment of cutaneous T-cell lymphoma.
Dearden C; Matutes E; Catovsky D
Oncology (Williston Park); 2000 Jun; 14(6 Suppl 2):37-40. PubMed ID: 10887643
[TBL] [Abstract][Full Text] [Related]
110. Frequency and Risk Factors for Associated Lymphomas in Patients With Lymphomatoid Papulosis.
Cordel N; Tressières B; D'Incan M; Machet L; Grange F; Estève É; Dalac S; Ingen-Housz-Oro S; Bagot M; Beylot-Barry M; Joly P;
Oncologist; 2016 Jan; 21(1):76-83. PubMed ID: 26668250
[TBL] [Abstract][Full Text] [Related]
111. IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases.
Pham-Ledard A; Prochazkova-Carlotti M; Laharanne E; Vergier B; Jouary T; Beylot-Barry M; Merlio JP
J Invest Dermatol; 2010 Mar; 130(3):816-25. PubMed ID: 19812605
[TBL] [Abstract][Full Text] [Related]
112. [Diagnosis and treatment for cutaneous T-cell lymphomas].
Hamada T; Iwatsuki K
Nihon Rinsho; 2012 Apr; 70 Suppl 2():537-43. PubMed ID: 23134012
[No Abstract] [Full Text] [Related]
113. Early detection of cutaneous lymphoma.
Abd-el-Baki J; Stefanato CM; Koh HK; Demierre MF; Foss FM
Oncology (Williston Park); 1998 Oct; 12(10):1521-30; discussion 1532-4. PubMed ID: 9798206
[TBL] [Abstract][Full Text] [Related]
114. Hyperpigmented mycosis fungoides: an unusual variant of cutaneous T-cell lymphoma with a frequent CD8+ phenotype.
Pavlovsky L; Mimouni D; Amitay-Laish I; Feinmesser M; David M; Hodak E
J Am Acad Dermatol; 2012 Jul; 67(1):69-75. PubMed ID: 21982059
[TBL] [Abstract][Full Text] [Related]
115. Low Drosha protein expression in cutaneous T-cell lymphoma is associated with worse disease outcome.
Gambichler T; Salveridou K; Schmitz L; Käfferlein HU; Brüning T; Stockfleth E; Sand M; Lang K
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1695-1699. PubMed ID: 31055868
[TBL] [Abstract][Full Text] [Related]
116. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins.
Boulland ML; Wechsler J; Bagot M; Pulford K; Kanavaros P; Gaulard P
Histopathology; 2000 Feb; 36(2):136-44. PubMed ID: 10672058
[TBL] [Abstract][Full Text] [Related]
117. Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3.
Booken N; Gratchev A; Utikal J; Weiss C; Yu X; Qadoumi M; Schmuth M; Sepp N; Nashan D; Rass K; Tüting T; Assaf C; Dippel E; Stadler R; Klemke CD; Goerdt S
Leukemia; 2008 Feb; 22(2):393-9. PubMed ID: 18033314
[TBL] [Abstract][Full Text] [Related]
118. Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma.
Gill RPK; Gantchev J; Martínez Villarreal A; Ramchatesingh B; Netchiporouk E; Akilov OE; Ødum N; Gniadecki R; Koralov SB; Litvinov IV
Cells; 2022 Feb; 11(4):. PubMed ID: 35203244
[TBL] [Abstract][Full Text] [Related]
119. Cutaneous lymphomas: an update. Part 1: T-cell and natural killer/t-cell lymphomas and related conditions.
Kempf W; Kazakov DV; Kerl K
Am J Dermatopathol; 2014 Feb; 36(2):105-23. PubMed ID: 24556897
[TBL] [Abstract][Full Text] [Related]
120.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]